REFERRAL FOR PHARMACOLOGIC TESTING, A MARKER OF POOR EXERCISE CAPACITY, CONFERS A HIGHER RISK OF SHORT AND LONG TERM MORTALITY THAN MOST TRADITIONAL CARDIAC RISK FACTORS EXCEPT AGE

After adjusting for cardiac risk factors (table in figure 1) and medication use, pharm. testing was the second most important risk factor for death (after age >65) with an adjusted HR of 2.82 (2.73-2.91), p

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2017-03, Vol.69 (11), p.1670-1670
Main Authors: Harb, Serge C, Wu, Yuping, Cho, Leslie, Rouphael, Carol, Cremer, Paul, Menon, Venu, Jaber, Wael
Format: Article
Language:English
Subjects:
Age
Bank portfolios
Banking industry
Cardiology
Cardiovascular
Internal Medicine
Survival analysis
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:After adjusting for cardiac risk factors (table in figure 1) and medication use, pharm. testing was the second most important risk factor for death (after age >65) with an adjusted HR of 2.82 (2.73-2.91), p
ISSN:0735-1097
1558-3597
DOI:10.1016/S0735-1097(17)35059-3